The EBMT activity survey 2008: impact of team size, team density and new trends.
about
Why has demand for platelet components increased? A reviewThe EBMT activity survey: 1990-2010Incidence and mortality trends of leukemia and lymphoma in Croatia, 1988-2009Hematopoietic SCT in Europe: data and trends in 2011.Hematopoietic SCT in Europe: data and trends in 2012 with special consideration of pediatric transplantationUse of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report.Hematopoietic stem cell transplantation rates and long-term survival in acute myeloid and lymphoblastic leukemia: real-world population-based data from the Swedish Acute Leukemia Registry 1997-2006.The treatment of chronic graft-versus-host disease: consensus recommendations of experts from Germany, Austria, and Switzerland.Hematopoietic progenitor cell collection in patients with chronic myelogenous leukemia in complete cytogenetic remission after imatinib mesylate therapyThe CXCR4 and adhesion molecule expression of CD34+ hematopoietic cells mobilized by "on-demand" addition of plerixafor to granulocyte-colony-stimulating factor.Oral care in Brazilian bone marrow transplant centersCryopreservation of Human Stem Cells for Clinical Application: A ReviewHematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants.Acute myeloid leukemia in the real world: why population-based registries are needed.Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually.Novel strategies for blood stem cell mobilization: special focus on plerixafor.Preemptive use of plerixafor in difficult-to-mobilize patients: an emerging concept.How do we mobilize and collect autologous peripheral blood stem cells?Ongoing graft-versus-host disease is a risk factor for azoospermia after allogeneic hematopoietic stem cell transplantation: a survey of the Late Effects Working Party of the European Group for Blood and Marrow TransplantationNew strategies for stem cell mobilization.Second time a charm? Remobilization of peripheral blood stem cells with plerixafor in patients who previously mobilized poorly despite using plerixafor as a salvage agent.A Phase II study on the safety and efficacy of a single dose of pegfilgrastim for mobilization and transplantation of autologous hematopoietic stem cells in pediatric oncohematology patients.Sensitivity of hematological malignancies to graft-versus-host effects: an EBMT megafile analysis.Plerixafor to the rescue: boosting peripheral blood stem cell mobilization in patients previously treated with hyperfractionated cyclophosphamide, vincristine, doxorubicin, dexamethasone/methotrexate, cytarabine (Hyper-CVAD) chemotherapy.The EBMT activity survey 2009: trends over the past 5 years.
P2860
Q28249969-736807DA-D221-4D8D-B193-067E4E0609C9Q28265604-1B3E398C-99B8-4856-AFF5-EDCEDA5D5990Q28384021-1B92BE20-90C2-4CD2-978A-EAC5AAB7E371Q30616418-D9198896-BB4F-4A5E-B196-C320269E552EQ33733022-48E51E19-F884-49CE-A187-1081D5D3804DQ33786536-1B1A6470-D1BE-49DE-A672-4477FAEFE0B6Q33841129-627E74B6-FDF5-4F03-996F-F5FB3379E3B6Q34082721-3CDCDE64-7A6A-4171-B001-1E4844FBF0C1Q34302673-BD06BB2B-B1C4-4D9F-A9A0-A8D1730151FBQ34432943-51DA84D1-5483-4652-B573-8CE82CA776EFQ34531124-0B086BA0-F3A7-48E7-9A5D-F1A31BEDACC7Q34939259-D15D982F-4125-40E8-A7AA-FC46F0ECB5F8Q35288778-5AFF2D38-32F0-406A-81C0-FA017B4DEAD7Q35980291-4D69CFE8-3A85-47DF-A72C-FF416876FD0CQ36974379-B8A735D5-A9E9-438A-A8B9-11255CB8E24BQ37909447-064207DA-AECB-4F18-9BD7-5236C4C354DDQ37943423-7D09B8C6-A9AF-48E8-A20E-843DCC38D737Q38978669-BFA37759-75DE-4592-97D4-8EAD04E5BDEFQ40889684-7942CCA4-3589-46D9-A0BA-C53FB3584E5EQ41104670-11111CFD-9D3F-4822-A719-BB3850F35BBEQ43563982-7199654E-C294-499D-BDCC-630DFF0E4784Q44065898-2B5C778F-B557-4598-8A5D-109F535A9CADQ44477645-C2A97D84-7F08-4333-A6E1-FDFC8B19BB4AQ44923993-5A70BB99-6036-48B1-AFE3-1242F2BD7782Q51887666-B050192A-B822-4116-BD12-15BFEE830A97
P2860
The EBMT activity survey 2008: impact of team size, team density and new trends.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
The EBMT activity survey 2008: impact of team size, team density and new trends.
@en
The EBMT activity survey 2008: impact of team size, team density and new trends.
@nl
type
label
The EBMT activity survey 2008: impact of team size, team density and new trends.
@en
The EBMT activity survey 2008: impact of team size, team density and new trends.
@nl
prefLabel
The EBMT activity survey 2008: impact of team size, team density and new trends.
@en
The EBMT activity survey 2008: impact of team size, team density and new trends.
@nl
P2093
P2860
P356
P1476
The EBMT activity survey 2008: impact of team size, team density and new trends.
@en
P2093
A Gratwohl
A Schwendener
D Niederwieser
H Baldomero
J Apperley
K Frauendorfer
M Gratwohl
P2860
P2888
P304
P356
10.1038/BMT.2010.69
P407
P577
2010-03-29T00:00:00Z
P5875
P6179
1007837004